SAA1 and COVID-19: The SAA levels were, on average, 3.1-fold higher in COVID-19 platelet lysates from mild patients compared to those from the controls and 4.8-fold and 4.4-fold higher in the platelets from moderate and severe patients, respectively (Figure 1D).